Literature DB >> 9856420

How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

C Cortet-Rudelli1, D Dewailly.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9856420     DOI： 10.1007/BF03350791

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  37 in total

1.  The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.

Authors:  M J Graf; C J Richards; V Brown; L Meissner; A Dunaif
Journal:  Clin Endocrinol (Oxf)       Date:  1990-07       Impact factor: 3.478

Review 2.  Insulin regulation of human ovarian androgens.

Authors:  J E Nestler
Journal:  Hum Reprod       Date:  1997-10       Impact factor: 6.918

3.  Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  R A Wild; P C Painter; P B Coulson; K B Carruth; G B Ranney
Journal:  J Clin Endocrinol Metab       Date:  1985-11       Impact factor: 5.958

4.  Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome.

Authors:  R Pasquali; F Casimirri; S Venturoli; M Antonio; L Morselli; S Reho; A Pezzoli; R Paradisi
Journal:  Metabolism       Date:  1994-06       Impact factor: 8.694

5.  Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

Authors:  D Apter; T Bützow; G A Laughlin; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

6.  Markers of abdominal adipose tissue in women: relationship to ovarian function.

Authors:  D Dewailly; C Cortet-Rudelli; D Deroubaix-Allard
Journal:  Trends Endocrinol Metab       Date:  1998-02       Impact factor: 12.015

7.  Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I.

Authors:  D S Kiddy; D Hamilton-Fairley; M Seppälä; R Koistinen; V H James; M J Reed; S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1989-12       Impact factor: 3.478

8.  Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.

Authors:  J Holte; T Bergh; C Berne; L Wide; H Lithell
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

9.  The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.

Authors:  J Holte; T Bergh; G Gennarelli; L Wide
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

10.  Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

Authors:  E Dahlgren; S Johansson; G Lindstedt; F Knutsson; A Odén; P O Janson; L A Mattson; N Crona; P A Lundberg
Journal:  Fertil Steril       Date:  1992-03       Impact factor: 7.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.